Cargando…
Commentary: A Special Edition in bone sarcoma
Autores principales: | Ludwig, Joseph A, Van Tine, Brian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9062412/ https://www.ncbi.nlm.nih.gov/pubmed/35517059 http://dx.doi.org/10.1016/j.jbo.2022.100426 |
Ejemplares similares
-
Targeting the IGF/PI3K/mTOR pathway and AXL/YAP1/TAZ pathways in primary bone cancer
por: Truong, Danh D., et al.
Publicado: (2022) -
One oncogene, several vulnerabilities: EWS/FLI targeted therapies for Ewing sarcoma
por: Flores, Guillermo, et al.
Publicado: (2021) -
The perplexing role of immuno-oncology drugs in osteosarcoma
por: Smrke, Alannah, et al.
Publicado: (2021) -
CD44 expression is correlated with osteosarcoma cell progression and immune infiltration and affects the Wnt/β-catenin signaling pathway
por: Ji, Hairu, et al.
Publicado: (2023) -
Early symptoms of bone and soft tissue sarcomas: could they be diagnosed earlier?
por: George, A, et al.
Publicado: (2012)